Barry Ritholtz speaks with Dana Mattioli, an investigative reporter covering Amazon for the Wall Street Journal. Since starting at the Journal in 2006 Dana has produced a string of front-page articles on everything from the troubles at Kodak and J.C. Penney to Pfizer's $150 billion deal to buy Allergan. She was a recipient of the 2021 Gerald Loeb Award for Beat Reporting as well as the 2021 WERT Prize from the Women’s Economic Round Table. Additionally, she was part of a 2016 Gerald Loeb Award team win in the breaking news category and a Pulitzer Prize finalist in 2020 for her team's investigation into Amazon. She is the author of the book "The Everything War: Amazon’s Ruthless Quest to Own the World and Remake Corporate Power." On this episode, Barry and Dana discuss her path into journalism, the current era of antitrust enforcement, and Amazon's growth into the powerhouse it is today.

See omnystudio.com/listener for privacy information.

We know it’s challenging, but should you try your hand at stock picking? It's fun, it gives you something to talk about at parties, but is it profitable? Larry Swedroe, Head of Financial and Economic Research at Buckingham Strategic Wealth, which manages or advises on $70 Billion in client assets, speaks with Barry Ritholtz about the challenges of picking stocks. Only a few people have been successful at it over time, and they have become household names. Most of the rest have not earned their costs.

See omnystudio.com/listener for privacy information.

Finding and onboarding new suppliers is a time-consuming process for procurement staff. Dun & Bradstreet has partnered with IBM to apply artificial intelligence to the process, enabling staff to query its databases in plain English to find suppliers who fit the criteria they need. The result is a simpler, faster process that is saving companies time and money. This episode is sponsored by IBM. 

See omnystudio.com/listener for privacy information.

Barry Ritholtz speaks with Tony Kim, Managing Director and Head of the Fundamental Equities’ Global Technology Team at BlackRock. Prior to joining BlackRock in 2013, Tony held key roles at institutions like Artisan Partners, Neuberger Berman, and Merrill Lynch. He is also a member of the Advisory Board for Columbia Business School’s Digital Future Initiative. On this episode, Barry and Tony discuss the success of passive investing at BlackRock, the general tech investing landscape, and what it takes to build a career that combines a passion for technology with finance.

See omnystudio.com/listener for privacy information.

Wall Street is always looking for an edge over the competition. But what if there was a giant source of overlooked alpha? Phil Pearlman, former Chief Behavioral Officer at the Bank of the Ozarks and founder of the Pearl Institute speaks with Barry Ritholtz about how the traders are seeking better returns by optimizing for personal health.

Each week, “At the Money” discusses an important topic in money management. From portfolio construction to taxes and cutting down on fees, join Barry Ritholtz to learn the best ways to put your money to work.

See omnystudio.com/listener for privacy information.

Barry Ritholtz speaks with David Roux, co-founder and executive chairman of BayPine, a private equity firm focused on digital transformation at core economy businesses. Previously he co-founded Silver Lake Partners and served as the chairman and co-CEO. David has also held leadership positions at Oracle, Central Point and Lotus Development. He currently serves on the boards of Bristol Seafoods and The Institute for Health Metrics and Evaluation at the University of Washington. On this episode, Barry and David discuss the tech investing landscape, AI's future development, and sectors of opportunity for BayPine's "digital transformation capital."

See omnystudio.com/listener for privacy information.

Are you holding large, concentrated equity positions that have accrued big gains? Would you like to diversify but also defer paying big capital gains taxes? Meb Faber, founder and chief investment officer of Cambria Investments, speaks with Barry Ritholtz about a new ETF that may be the solution to the challenge of concentrated equity positions. 

Each week, “At the Money” discusses an important topic in money management. From portfolio construction to taxes and cutting down on fees, join Barry Ritholtz to learn the best ways to put your money to work.

See omnystudio.com/listener for privacy information.

Barry Ritholtz speaks with Michael Morris, cultural psychologist and Chavkin-Chang Professor of Leadership at the Columbia Business School. Prior to joining Columbia, Michael was a tenured professor at Stanford's Graduate School of Business and Psychology Department. He also served as a visiting professor at various institutions including the University of Hong Kong and Harvard Business School. Michael has published over 200 articles in leading behavioral science journals and has received countless international awards from scholarly societies across several fields. Michael serves as a consulting editor at the Journal of International Business and at Management and Organization Review. On this episode, Barry and Michael discuss the connection between psychology and leadership, the basic tribal instincts that drive us, and his new book Tribal: How the Cultural Instincts That Divide Us Can Help Bring Us Together.

See omnystudio.com/listener for privacy information.

Are you crypto-curious? Are you interested in owning some bitcoin, Ethereum, or other crypto-coins? How can investors get exposure to the space? Matt Hougan, Chief Investment Officer at Bitwise Asset Management speaks with Barry Ritholtz about the best ways to responsibly manage crypto assets. His firm runs over $10 billion in client crypto assets.

See omnystudio.com/listener for privacy information.

Damian Sanchez, (Damian J to music fans) is a Miami-based jazz musician. A car accident landed him in the hospital with multiple fractures to his leg. Once there, he faced the difficult decision of whether or not to take the pain medication that was offered to him. With patients like Damian in mind, Dr. Paul Negulescu and the research team at Vertex are thinking differently about pain – they’re investigating potential non-opioid based treatment options that aim to target pain differently.

This episode of Targeting the Toughest Diseases is sponsored by Vertex Pharmaceuticals.

See omnystudio.com/listener for privacy information.